PDK3 and urinary bladder carcinoma: EA exhibits in vitro and in vivo anti-tumor activity for human bladder cancer.Inhibits tumor cell proliferation; migration and invasion.Down-regulation of PD-L1 and reduction of angiogenesis.Inhibition of kinase-related pathways such as PI3K/AKT, PDK3, and SPHK.